SF3B1 and myelodysplastic syndrome: For example, SF3B1 mutations in myelodysplastic syndromes specifically impair the erythroid lineage by inducing mis-splicing of MAP3K7, which leads to p38 MAPK inactivation and premature downregulation of GATA1, thereby blocking terminal erythroid differentiation [7].